Joseph Miller
Financieel Directeur/CFO bij AURINIA PHARMACEUTICALS INC.
Vermogen: 2 M $ op 30-04-2024
Actieve functies van Joseph Miller
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AURINIA PHARMACEUTICALS INC. | Financieel Directeur/CFO | 27-04-2020 | - |
Loopbaan van Joseph Miller
Eerdere bekende functies van Joseph Miller
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AVALO THERAPEUTICS, INC. | Directeur/Bestuurslid | 24-04-2020 | 01-06-2022 |
Financieel Directeur/CFO | 12-07-2018 | 24-04-2020 | |
Bedrijfssecretaris | - | 24-04-2020 | |
SUCAMPO PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 01-01-2015 | 01-04-2018 |
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Comptroller/Controller/Auditor | 01-01-2006 | 01-01-2015 |
Eppendorf-5 Prime, Inc. | Financieel Directeur/CFO | 01-01-2002 | 01-01-2006 |
Opleiding van Joseph Miller
Villanova University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Canada | 2 |
Operationeel
Director of Finance/CFO | 4 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AVALO THERAPEUTICS, INC. | Health Technology |
AURINIA PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Eppendorf-5 Prime, Inc. |
- Beurs
- Insiders
- Joseph Miller
- Ervaring